578 related articles for article (PubMed ID: 29714486)
21. Gallium-67-labeled lactam bridge-cyclized alpha-melanocyte stimulating hormone peptide for primary and metastatic melanoma imaging.
Guo H; Yang J; Shenoy N; Miao Y
Bioconjug Chem; 2009 Dec; 20(12):2356-63. PubMed ID: 19919057
[TBL] [Abstract][Full Text] [Related]
22. Radiopharmacological characterization of ⁶⁴Cu-labeled α-MSH analogs for potential use in imaging of malignant melanoma.
Gao F; Sihver W; Jurischka C; Bergmann R; Haase-Kohn C; Mosch B; Steinbach J; Carta D; Bolzati C; Calderan A; Pietzsch J; Pietzsch HJ
Amino Acids; 2016 Mar; 48(3):833-847. PubMed ID: 26643502
[TBL] [Abstract][Full Text] [Related]
23. Tc-99m-labeled RGD-conjugated alpha-melanocyte stimulating hormone hybrid peptides with reduced renal uptake.
Yang J; Hu CA; Miao Y
Amino Acids; 2015 Apr; 47(4):813-23. PubMed ID: 25557051
[TBL] [Abstract][Full Text] [Related]
24. Melanocortin 1 Receptor Targeted Imaging of Melanoma With Gold Nanocages and Positron Emission Tomography.
Zhao Y; Pang B; Detering L; Luehmann H; Yang M; Black K; Sultan D; Xia Y; Liu Y
Mol Imaging; 2018; 17():1536012118775827. PubMed ID: 29873290
[TBL] [Abstract][Full Text] [Related]
25. Metastatic melanoma imaging with an (111)In-labeled lactam bridge-cyclized alpha-melanocyte-stimulating hormone peptide.
Guo H; Shenoy N; Gershman BM; Yang J; Sklar LA; Miao Y
Nucl Med Biol; 2009 Apr; 36(3):267-76. PubMed ID: 19324272
[TBL] [Abstract][Full Text] [Related]
26. 111In-labeled lactam bridge-cyclized alpha-melanocyte stimulating hormone peptide analogues for melanoma imaging.
Miao Y; Gallazzi F; Guo H; Quinn TP
Bioconjug Chem; 2008 Feb; 19(2):539-47. PubMed ID: 18197608
[TBL] [Abstract][Full Text] [Related]
27. A novel DOTA-alpha-melanocyte-stimulating hormone analog for metastatic melanoma diagnosis.
Froidevaux S; Calame-Christe M; Tanner H; Sumanovski L; Eberle AN
J Nucl Med; 2002 Dec; 43(12):1699-706. PubMed ID: 12468522
[TBL] [Abstract][Full Text] [Related]
28. Effects of Polyethylene Glycol and 8-Aminooctanoic Acid Linkers on Melanoma Uptake of [
Qiao Z; Xu J; Gonzalez R; Miao Y
Bioconjug Chem; 2023 May; 34(5):934-940. PubMed ID: 37140963
[TBL] [Abstract][Full Text] [Related]
29. Introduction of an 8-aminooctanoic acid linker enhances uptake of 99mTc-labeled lactam bridge-cyclized α-MSH peptide in melanoma.
Guo H; Miao Y
J Nucl Med; 2014 Dec; 55(12):2057-63. PubMed ID: 25453052
[TBL] [Abstract][Full Text] [Related]
30. Substitution of the Lys linker with the β-Ala linker dramatically decreased the renal uptake of 99mTc-labeled Arg-X-Asp-conjugated and X-Ala-Asp-conjugated α-melanocyte stimulating hormone peptides.
Flook AM; Yang J; Miao Y
J Med Chem; 2014 Nov; 57(21):9010-8. PubMed ID: 25290883
[TBL] [Abstract][Full Text] [Related]
31. Radioiodination of rhenium cyclized alpha-melanocyte-stimulating hormone resulting in enhanced radioactivity localization and retention in melanoma.
Cheng Z; Chen J; Quinn TP; Jurisson SS
Cancer Res; 2004 Feb; 64(4):1411-8. PubMed ID: 14973076
[TBL] [Abstract][Full Text] [Related]
32. Reduction of the ring size of radiolabeled lactam bridge-cyclized alpha-MSH peptide, resulting in enhanced melanoma uptake.
Guo H; Yang J; Gallazzi F; Miao Y
J Nucl Med; 2010 Mar; 51(3):418-26. PubMed ID: 20150256
[TBL] [Abstract][Full Text] [Related]
33. (18)F-trifluoroborate derivatives of [des-arg(10)]kallidin for imaging bradykinin b1 receptor expression with positron emission tomography.
Liu Z; Amouroux G; Zhang Z; Pan J; Hundal-Jabal N; Colpo N; Lau J; Perrin DM; Bénard F; Lin KS
Mol Pharm; 2015 Mar; 12(3):974-82. PubMed ID: 25629412
[TBL] [Abstract][Full Text] [Related]
34. Melanoma-targeting properties of (99m)technetium-labeled cyclic alpha-melanocyte-stimulating hormone peptide analogues.
Chen J; Cheng Z; Hoffman TJ; Jurisson SS; Quinn TP
Cancer Res; 2000 Oct; 60(20):5649-58. PubMed ID: 11059756
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of an (111)In-DOTA-rhenium cyclized alpha-MSH analog: a novel cyclic-peptide analog with improved tumor-targeting properties.
Chen J; Cheng Z; Owen NK; Hoffman TJ; Miao Y; Jurisson SS; Quinn TP
J Nucl Med; 2001 Dec; 42(12):1847-55. PubMed ID: 11752084
[TBL] [Abstract][Full Text] [Related]
36. Facile preparation of a novel Ga-67-labeled NODAGA-conjugated lactam-cyclized alpha-MSH peptide at room temperature for melanoma targeting.
Xu J; Qiao Z; Gonzalez R; Miao Y
Bioorg Med Chem Lett; 2020 Dec; 30(24):127627. PubMed ID: 33141072
[TBL] [Abstract][Full Text] [Related]
37. Novel, cysteine-modified chelation strategy for the incorporation of [M(I)(CO)(3)](+) (M = Re, (99m)Tc) in an α-MSH peptide.
Jiang H; Kasten BB; Liu H; Qi S; Liu Y; Tian M; Barnes CL; Zhang H; Cheng Z; Benny PD
Bioconjug Chem; 2012 Nov; 23(11):2300-12. PubMed ID: 23110503
[TBL] [Abstract][Full Text] [Related]
38. The pharmacological properties of 3-arm or 4-arm DOTA constructs for conjugation to α-melanocyte-stimulating hormone analogues for melanoma imaging.
Kobayashi M; Kato T; Washiyama K; Ihara M; Mizutani A; Nishi K; Flores LG; Nishii R; Kawai K
PLoS One; 2019; 14(3):e0213397. PubMed ID: 30901323
[TBL] [Abstract][Full Text] [Related]
39. Gallium-67-labeled lactam bridge-cyclized alpha-MSH peptides with enhanced melanoma uptake and reduced renal uptake.
Guo H; Gallazzi F; Miao Y
Bioconjug Chem; 2012 Jun; 23(6):1341-8. PubMed ID: 22621181
[TBL] [Abstract][Full Text] [Related]
40. [111In]-DTPA-labeled analogues of alpha-melanocyte-stimulating hormone for melanoma targeting: receptor binding in vitro and in vivo.
Bagutti C; Stolz B; Albert R; Bruns C; Pless J; Eberle AN
Int J Cancer; 1994 Sep; 58(5):749-55. PubMed ID: 8077062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]